Comparative field study: impact of laboratory assay variability on the assessment of recombinant factor IX Fc fusion protein (rFIXFc) activity

類似資料

• Population Pharmacokinetic Modelling of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Patients with Haemophilia B
  著者:: Diao, Lei, 等
  出版事項: (2014)
• Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
  著者:: Shapiro, Amy D., 等
  出版事項: (2012)
• Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice
  著者:: Toby, Garabet G., 等
  出版事項: (2016)
• Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories
  著者:: Sommer, J M, 等
  出版事項: (2014)
• Real‐world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples
  著者:: Sommer, Jurg M., 等
  出版事項: (2020)